Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France

This cohort study assesses the incidence and severity of COVID-19 among vaccinated recipients of allogenic stem cell transplant in a single center after 1 or 2 messenger RNA booster doses during the Omicron wave in France.

Detalles Bibliográficos
Autores principales: Letailleur, Valentin, Le Bourgeois, Amandine, Guillaume, Thierry, Jullien, Maxime, Coste-Burel, Marianne, Béné, Marie C., Chevallier, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856420/
https://www.ncbi.nlm.nih.gov/pubmed/36534404
http://dx.doi.org/10.1001/jamanetworkopen.2022.47534
_version_ 1784873624186912768
author Letailleur, Valentin
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Coste-Burel, Marianne
Béné, Marie C.
Chevallier, Patrice
author_facet Letailleur, Valentin
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Coste-Burel, Marianne
Béné, Marie C.
Chevallier, Patrice
author_sort Letailleur, Valentin
collection PubMed
description This cohort study assesses the incidence and severity of COVID-19 among vaccinated recipients of allogenic stem cell transplant in a single center after 1 or 2 messenger RNA booster doses during the Omicron wave in France.
format Online
Article
Text
id pubmed-9856420
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-98564202023-02-03 Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France Letailleur, Valentin Le Bourgeois, Amandine Guillaume, Thierry Jullien, Maxime Coste-Burel, Marianne Béné, Marie C. Chevallier, Patrice JAMA Netw Open Research Letter This cohort study assesses the incidence and severity of COVID-19 among vaccinated recipients of allogenic stem cell transplant in a single center after 1 or 2 messenger RNA booster doses during the Omicron wave in France. American Medical Association 2022-12-19 /pmc/articles/PMC9856420/ /pubmed/36534404 http://dx.doi.org/10.1001/jamanetworkopen.2022.47534 Text en Copyright 2022 Letailleur V et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Letailleur, Valentin
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Coste-Burel, Marianne
Béné, Marie C.
Chevallier, Patrice
Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France
title Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France
title_full Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France
title_fullStr Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France
title_full_unstemmed Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France
title_short Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France
title_sort assessment of covid-19 incidence and severity among recipients of allogenic stem cell transplant after 1 or 2 mrna booster doses during the omicron wave in france
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856420/
https://www.ncbi.nlm.nih.gov/pubmed/36534404
http://dx.doi.org/10.1001/jamanetworkopen.2022.47534
work_keys_str_mv AT letailleurvalentin assessmentofcovid19incidenceandseverityamongrecipientsofallogenicstemcelltransplantafter1or2mrnaboosterdosesduringtheomicronwaveinfrance
AT lebourgeoisamandine assessmentofcovid19incidenceandseverityamongrecipientsofallogenicstemcelltransplantafter1or2mrnaboosterdosesduringtheomicronwaveinfrance
AT guillaumethierry assessmentofcovid19incidenceandseverityamongrecipientsofallogenicstemcelltransplantafter1or2mrnaboosterdosesduringtheomicronwaveinfrance
AT jullienmaxime assessmentofcovid19incidenceandseverityamongrecipientsofallogenicstemcelltransplantafter1or2mrnaboosterdosesduringtheomicronwaveinfrance
AT costeburelmarianne assessmentofcovid19incidenceandseverityamongrecipientsofallogenicstemcelltransplantafter1or2mrnaboosterdosesduringtheomicronwaveinfrance
AT benemariec assessmentofcovid19incidenceandseverityamongrecipientsofallogenicstemcelltransplantafter1or2mrnaboosterdosesduringtheomicronwaveinfrance
AT chevallierpatrice assessmentofcovid19incidenceandseverityamongrecipientsofallogenicstemcelltransplantafter1or2mrnaboosterdosesduringtheomicronwaveinfrance

Ejemplares similares